Role of the endolysosomal system in Parkinson's disease
- PMID: 31287913
- PMCID: PMC6707858
- DOI: 10.1111/jnc.14820
Role of the endolysosomal system in Parkinson's disease
Abstract
Parkinson's disease (PD) is one of the most common neurodegenerative disorders, affecting 1-1.5% of the total population. While progress has been made in understanding the neurodegenerative mechanisms that lead to cell death in late stages of PD, mechanisms for early, causal pathogenic events are still elusive. Recent developments in PD genetics increasingly point at endolysosomal (E-L) system dysfunction as the early pathomechanism and key pathway affected in PD. Clathrin-mediated synaptic endocytosis, an integral part of the neuronal E-L system, is probably the main early target as evident in auxilin, RME-8, and synaptojanin-1 mutations that cause PD. Autophagy, another important pathway in the E-L system, is crucial in maintaining proteostasis and a healthy mitochondrial pool, especially in neurons considering their inability to divide and requirement to function an entire life-time. PINK1 and Parkin mutations severely perturb autophagy of dysfunctional mitochondria (mitophagy), both in the cell body and synaptic terminals of dopaminergic neurons, leading to PD. Endolysosomal sorting and trafficking is also crucial, which is complex in multi-compartmentalized neurons. VPS35 and VPS13C mutations noted in PD target these mechanisms. Mutations in GBA comprise the most common risk factor for PD and initiate pathology by compromising lysosomal function. This is also the case for ATP13A2 mutations. Interestingly, α-synuclein and LRRK2, key proteins involved in PD, function in different steps of the E-L pathway and target their components to induce disease pathogenesis. In this review, we discuss these E-L system genes that are linked to PD and how their dysfunction results in PD pathogenesis. This article is part of the Special Issue "Synuclein".
Keywords: Autophagy; Clathrin-mediated endocytosis; LRRK2; Lysosomes; Retromer complex; α-Synuclein.
© 2019 International Society for Neurochemistry.
Conflict of interest statement
Figures

Similar articles
-
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338. Int J Mol Sci. 2023. PMID: 37047309 Free PMC article. Review.
-
LRRK2 and the Endolysosomal System in Parkinson's Disease.J Parkinsons Dis. 2020;10(4):1271-1291. doi: 10.3233/JPD-202138. J Parkinsons Dis. 2020. PMID: 33044192 Free PMC article. Review.
-
Endosomal sorting pathways in the pathogenesis of Parkinson's disease.Prog Brain Res. 2020;252:271-306. doi: 10.1016/bs.pbr.2020.02.001. Epub 2020 Mar 16. Prog Brain Res. 2020. PMID: 32247367 Free PMC article. Review.
-
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.Trends Neurosci. 2019 Feb;42(2):140-149. doi: 10.1016/j.tins.2018.11.001. Epub 2018 Nov 30. Trends Neurosci. 2019. PMID: 30509690 Free PMC article. Review.
-
Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.Biomolecules. 2021 Sep 9;11(9):1333. doi: 10.3390/biom11091333. Biomolecules. 2021. PMID: 34572546 Free PMC article. Review.
Cited by
-
Differences in Neuronal Numbers, Morphology, and Developmental Apoptosis in Mice Nigra Provide Experimental Evidence of Ontogenic Origin of Vulnerability to Parkinson's Disease.Neurotox Res. 2021 Dec;39(6):1892-1907. doi: 10.1007/s12640-021-00439-6. Epub 2021 Nov 11. Neurotox Res. 2021. PMID: 34762290
-
De Novo Design of A Membrane-Anchored Probe for Multidimensional Quantification of Endocytic Dynamics.Adv Healthc Mater. 2022 Apr;11(8):e2102185. doi: 10.1002/adhm.202102185. Epub 2022 Jan 27. Adv Healthc Mater. 2022. PMID: 35032365 Free PMC article.
-
Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics.Int J Mol Med. 2021 Oct;48(4):195. doi: 10.3892/ijmm.2021.5028. Epub 2021 Sep 1. Int J Mol Med. 2021. PMID: 34468012 Free PMC article.
-
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338. Int J Mol Sci. 2023. PMID: 37047309 Free PMC article. Review.
-
MicroRNAs Regulating Cytoskeleton Dynamics, Endocytosis, and Cell Motility-A Link Between Neurodegeneration and Cancer?Front Neurol. 2020 Nov 9;11:549006. doi: 10.3389/fneur.2020.549006. eCollection 2020. Front Neurol. 2020. PMID: 33240194 Free PMC article. Review.
References
-
- Aharon-Peretz J, Rosenbaum H and Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med 351, 1972–1977. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous